This working paper has been commissioned by the Western Hemisphere Drug Policy Commission, a Congressionally established body mandated to evaluate U.S. drug policies and programs in the Western Hemisphere with the aim of making recommendations to the President and Congress on the future of counter narcotics policies. The topic discussed in this manuscript deals with matters of drug supply-oriented policies and interventions with a particular focus on available supply-side indicators used to inform contemporary drug policy, the limits of those indicators, the future challenges of drug policy, and how to improve indicators such that they appropriately incorporate harms.
This research was commissioned by the Western Hemisphere Drug Policy Commission and conducted by the Justice Policy Program within RAND Social and Economic Well-Being.
This report is part of the RAND Corporation working paper series. RAND working papers are intended to share researchers' latest findings and to solicit informal peer review. They have been approved for circulation by RAND but may not have been formally edited or peer reviewed.
Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.